Biotech Startup Receives More Funds to Advance its Drug Discovery Program LEXINGTON, Ky. and QUEENS, N.Y. (Oct. 12, 2017) – Gismo Therapeutics Inc. has been awarded two grants to continue its development of therapies to treat Parkinson’s Disease. A $384,000 SBIR grant entitled "Glycosaminoglycan-Interacting Small Molecule (GISMO) as Parkinson's Therapeutic" was awarded by the National [...]
About Gismo Therapeutics Inc.This author has not yet filled in any details.
So far Gismo Therapeutics Inc. has created 3 blog entries.
Biotech Startup, Collaborator Receive Parkinson's Disease Grant to Study Newly Identified Pathway, Develop Novel Treatments Lexington, Kentucky (PRWEB) December 03, 2014 Gismo Therapeutics Inc. is pleased to announce that it has been awarded a $235,000 Michael J. Fox Foundation for Parkinson's Research grant to investigate therapeutics directed against a newly identified disease pathway in Parkinson’s disease. [...]
Biotech Company Receives SBIR Grant, Identifies Lead Compounds and Files Patent Application Lexington,Kentucky and Queens, New York (PRWEB) October 02, 2014 Gismo Therapeutics Inc. is pleased to announce funding received to investigate therapeutics directed against a newly identified disease pathway in Alzheimer’s disease. A grant award from the Small Business Innovation Research (SBIR) Program, National Institute [...]